In this presentation, Dr. Kamyar Hadian (head of the #assay development and Screening Platform’ at the HelmholtzZentrum München in Munich/Germany) talk about #hcs use in #stem cell– and microtissue-based assays.
#phenotypic screening has highly emerged in the past years. Especially High-Content Screening (HCS) has gained strong acceptance in the field of target validation and compounds screening as a method to follow more innovative and sophisticated assays …
Curated from www.technologynetworks.com
0 Comments